Aerie Pharmaceuticals Inc (NASDAQ:AERI)

50.38
Delayed Data
As of 4:00pm ET
 -0.77 / -1.52%
Today’s Change
39.55
Today|||52-Week Range
66.60
-15.69%
Year-to-Date
9 Stocks Ron Baron Continues to Buy
May 17 / GuruFocus News - Paid Partner Content
Aerie (AERI) Incurs Lower Loss in Q1, Launches Rhopressa
May 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close51.15
Today’s open51.65
Day’s range50.03 - 51.65
Volume271,642
Average volume (3 months)339,225
Market cap$2.1B
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)-20.88%
Earnings growth (this year)-6.42%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.26

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-0.13-2.13%
AXONAxovant Sciences Ltd-0.08-6.15%
HZNPHorizon Pharma PLC-0.10-0.66%
PRTAProthena Corporation...-0.63-4.12%
Data as of 4:00pm ET, 05/21/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.98
Annual revenue (last year)$0.00
Annual profit (last year)-$145.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Vicente J. Anido
President &
Chief Operating Officer
Thomas A. Mitro
Corporate headquarters
Irvine, California

Forecasts